EUVIMEDEUVIMED entdecken
Open Access

Tobacco Cessation Following Laryngeal Cancer Diagnosis Predicts Response to Treatment and Laryngectomy‐Free Survival

Matthew Krutz, Pawan Acharya, Jacey Elliott, Daniel Zhao, Rachad Mhawej, Lurdes Queimado iD

Otolaryngology–Head and Neck Surgery · 2024-02 · 170 (2) · 438-446

DOI: 10.1002/ohn.567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 27.10.2023. Verfasst von Matthew Krutz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Tobacco Use Cessation, Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the effect of tobacco cessation following laryngeal cancer diagnosis on response to first‐line therapy, laryngectomy‐free survival, and overall survival in patients who were current smokers at the time of diagnosis. Study Design Retrospective, case‐control study.

Setting

OU Stephenson Cancer Center, National Cancer Institute‐Designated Cancer Center.

Methods

We included 140 patients diagnosed with laryngeal squamous cell carcinoma, who were current smokers at the time of diagnosis, and were treated with first‐line definitive radiation or chemo/radiation with the intent to cure. The association between patient characteristics and treatment response was assessed using the χ 2 test and logistic regression analysis. Survival outcomes were analyzed using Kaplan‐Meier methods and Cox proportional‐hazards models.

Results

Of the 140 current smokers, 61 patients (45%) quit smoking prior to treatment initiation. In adjusted logistic regression analysis, quitters had 3.7 times higher odds of achieving a complete response to first‐line therapy than active smokers (odds ratio: 3.694 [1.575‐8.661]; P = .003). In the adjusted Cox proportional‐hazards model, quitters were 54% less likely to require salvage laryngectomy within 7 years of diagnosis than active smokers (hazard ratio: 0.456 [0.246‐0.848]; P = .013). Quitters had a statistically significant increase in 7‐year overall survival compared to active smokers ( P = .02).

Conclusion

This is the first study to show that in newly diagnosed laryngeal cancer patients who are current smokers at the time of diagnosis, tobacco cessation significantly increases therapy response, laryngectomy‐free survival, and overall survival. These data stress the importance of systematically incorporating tobacco cessation programs into laryngeal cancer treatment plans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsTobacco Use CessationCarcinoma, Squamous CellHead and Neck NeoplasmsHumansLaryngectomyRetrospective StudiesCase-Control Studies

Stichwörter der Autor:innen

laryngeal cancerlaryngectomy-free survivaloverall survivalresponse to therapysquamous cell carcinomatobacco cessation

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Department of Biostatistics and Epidemiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

ORCID-Profile: Lurdes Queimado

Förderung

  • NCI NIH HHS

Zitieren

APA

Krutz, M., Acharya, P., Elliott, J., Zhao, D., Mhawej, R., & Queimado, L. (2024). Tobacco Cessation Following Laryngeal Cancer Diagnosis Predicts Response to Treatment and Laryngectomy‐Free Survival. Otolaryngology–Head and Neck Surgery, 170(2), 438-446. https://doi.org/10.1002/ohn.567

Vancouver

Krutz M, Acharya P, Elliott J, Zhao D, Mhawej R, Queimado L. Tobacco Cessation Following Laryngeal Cancer Diagnosis Predicts Response to Treatment and Laryngectomy‐Free Survival. Otolaryngology–Head and Neck Surgery. 2024;170(2):438-446. doi:10.1002/ohn.567

BibTeX
@article{Krutz2024,
  author = {Krutz, Matthew and Acharya, Pawan and Elliott, Jacey and Zhao, Daniel and Mhawej, Rachad and Queimado, Lurdes},
  title = {Tobacco Cessation Following Laryngeal Cancer Diagnosis Predicts Response to Treatment and Laryngectomy‐Free Survival},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  volume = {170},
  number = {2},
  pages = {438--446},
  doi = {10.1002/ohn.567}
}
Kostenlos starten →